BACPHARPharmaceuticals
Bacil Pharma Ltd — PE Ratio & Valuation Analysis
₹47.73
-1.10%
Current P/E93.40xPrice to earnings
Industry P/E31.77xSector average
⚠️
194.0% Premium to Industry
BACPHAR P/E 93.40x vs sector avg 31.77x
💡
Understanding Bacil Pharma Ltd Valuation
Bacil Pharma Ltd (BACPHAR) currently trades at 93.40x earnings. The Pharmaceuticals sector average PE is 31.77x. BACPHAR commands a premium, reflecting high growth expectations. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
-0.98%
Dividend Yield
0.00%
More on Bacil Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.